Filing metadata

Accession number
0001209191-22-038659
Form type
Form 3
Filer
Acer Therapeutics Inc.
CIK
CIK 1069308
Filed
Jun 22, 2022
Reporting period
Jun 19, 2022
Description
Initial ownership

Explore SEC Filings Hub